Interventional radiology is involved practically at each stage in the treatment of hepatocellular carcinoma, as recommended in the EASL-EORTC guidelines. It is even becoming more important as technological advances progress and as its long-term efficacy is assessed. Used curatively, thermoablation can obtain five-year survival rates of 40 to 70%, with a survival rate of 30% at 10years. As there are many tools available in order to be used, it requires a thorough pre-treatment assessment and discussion in a multidisciplinary team meeting. Regular patient reassessment is needed in order to be able to adjust treatment because of the complementarity of the treatments available and the course of the disease
none6noPurpose: This study was designed to provide an overview of the practice of locoregional treat...
Hepatocellular carcinoma (HCC) is one of the few cancers for which locoregional treatments (LRTs) ar...
Hepatocellular carcinoma (HCC) is one of the most refractory malignancies worldwide, and there are a...
AbstractInterventional radiology is involved practically at each stage in the treatment of hepatocel...
International audienceInterventional radiology is involved practically at each stage in the treatmen...
The incidence of hepatocellular carcinoma (HCC) in the UK is increasing. The role of interventional ...
Hepatocellular carcinoma (HCC) is the fifth most frequently found primary malignant tumor in the worl...
According to Barcelona Clinic Liver Cancer (BCLC) guidelines, interventional radiology procedures ar...
Hepatocellular carcinoma is the second most common cause of death from malignancy in Hong Kong. The ...
Surgical resection and imaging guided treatments play a crucial role in the management of hepatocell...
Background: To improve the survival rate of patients with hepatocellular carcinoma (HCC) in whom sur...
Hepatocellular carcinoma (HCC) is a major health problem worldwide, affecting more than 600,000 new ...
Hepatocellular carcinoma (HCC) is responsible for 90% of primary hepatic cancer cases, and its incid...
Hepatocelularni karcinom (HCC) jedan je od najčešćih karcinoma u čovjeka. Rizični čimbenici kao što ...
Abstract Hepatocellular carcinoma (HCC) is a primary malignant tumor of the liver that accounts for ...
none6noPurpose: This study was designed to provide an overview of the practice of locoregional treat...
Hepatocellular carcinoma (HCC) is one of the few cancers for which locoregional treatments (LRTs) ar...
Hepatocellular carcinoma (HCC) is one of the most refractory malignancies worldwide, and there are a...
AbstractInterventional radiology is involved practically at each stage in the treatment of hepatocel...
International audienceInterventional radiology is involved practically at each stage in the treatmen...
The incidence of hepatocellular carcinoma (HCC) in the UK is increasing. The role of interventional ...
Hepatocellular carcinoma (HCC) is the fifth most frequently found primary malignant tumor in the worl...
According to Barcelona Clinic Liver Cancer (BCLC) guidelines, interventional radiology procedures ar...
Hepatocellular carcinoma is the second most common cause of death from malignancy in Hong Kong. The ...
Surgical resection and imaging guided treatments play a crucial role in the management of hepatocell...
Background: To improve the survival rate of patients with hepatocellular carcinoma (HCC) in whom sur...
Hepatocellular carcinoma (HCC) is a major health problem worldwide, affecting more than 600,000 new ...
Hepatocellular carcinoma (HCC) is responsible for 90% of primary hepatic cancer cases, and its incid...
Hepatocelularni karcinom (HCC) jedan je od najčešćih karcinoma u čovjeka. Rizični čimbenici kao što ...
Abstract Hepatocellular carcinoma (HCC) is a primary malignant tumor of the liver that accounts for ...
none6noPurpose: This study was designed to provide an overview of the practice of locoregional treat...
Hepatocellular carcinoma (HCC) is one of the few cancers for which locoregional treatments (LRTs) ar...
Hepatocellular carcinoma (HCC) is one of the most refractory malignancies worldwide, and there are a...